Abstract: Disclosed herein are devices, systems, and methods for self-sanitizing a device using the built-in screen display of the device (e.g., a laptop). The device includes a processor configured to execute instructions to determine a relationship between a location of a display of the device and a location of a keyboard surface of the device. The processor is also configured to execute instructions configured to, based on the relationship, enable a sanitization mode on the device and to configure the display to emit light toward the keyboard surface to sanitize the keyboard surface when the sanitization mode is enabled.

Abstract: The present invention relates to methods and devices for providing microbial control and/or disinfection/remediation of an environment. The methods generally comprise generating a Purified Hydrogen Peroxide Gas (PHPG) that is substantially free of, e.g., hydration, ozone, plasma species, and/or organic species; and directing the gas comprising primarily PHPG into the environment such that the PHPG acts to provide microbial control and/or disinfection/remediation in the environment, preferably both on surfaces and in the air.

Abstract: Various examples disclosed relate to a device for use in a disinfection process. The device can include, for example, a sampling assembly capable of a first position and a second position, wherein the sampling assembly is configured to be used inside a sterilization system. The sampling assembly can include a top portion, a bottom portion, at least one seal therebetween such that the top portion and the bottom portion form an airtight compartment when in the first position, a central pin running through the top portion and bottom portion, and an actuator configured to move the sampling assembly between the first position and the second position along the central pin during a portion of the disinfection process, such that the sampling assembly can collect a sample of atmosphere within the disinfection system.

Abstract: The aspects presented herein provides malodor masking compositions and/or ingredients, methods for counteracting or masking malodors, and perfuming compositions having odor masking properties.

Abstract: A scent dispenser may comprise a vial retaining mechanism, a heating element, vial sensor, and a controller. The vial retaining mechanism includes a vial coupling that removeably retains a vial containing a scented solution. The includes a wick extending from a cavity of the vial through an opening of a neck of the vial. The heating element is shaped to receive and heat the wick of the vial. The vial sensor includes an array of sensor pads that are arranged in alignment with the vial retained by the vial coupling. The controller is electrically coupled to the heating element and electrically coupled to the array of sensor pads. The controller regulates a temperature level of the heating element, and receives signals from the array of sensor pads and processing the signals to determine a fluid level of the vial.

Abstract: A scent dispenser may comprise a vial retaining mechanism, a heating element, vial sensor, and a controller. The vial retaining mechanism includes a vial coupling that removeably retains a vial containing a scented solution. The includes a wick extending from a cavity of the vial through an opening of a neck of the vial. The heating element is shaped to receive and heat the wick of the vial. The vial sensor includes an array of sensor pads that are arranged in alignment with the vial retained by the vial coupling. The controller is electrically coupled to the heating element and electrically coupled to the array of sensor pads. The controller regulates a temperature level of the heating element, and receives signals from the array of sensor pads and processing the signals to determine a fluid level of the vial.

Abstract: A breathing apparatus disinfection device and system that has a replaceable inner tube member and helical radiation source for disinfecting air from a ventilator before it reaches a patient. The breathing apparatus disinfection device and system comprises an inner tube member surrounded by a helical shaped radiation source. An outer tube member comprises end caps or modular shield blockers that prevent any radiation from reaching outside the breathing apparatus disinfection device and into the immediate environment, thereby reducing or eliminating unwanted patient or user contamination exposure.

Abstract: An air purifier includes a case having an air inlet and an air outlet, a fan disposed adjacent the air inlet, a UV LED unit and a filter unit arranged over the fan along a flow path of air, and a fluid control structure disposed between the fan and the filter unit.

Abstract: The present invention provides a surgical thread, comprising a modified cross-section fiber, wherein the modified cross-section fiber is in a twisted state. The surgical thread of the present invention has advantages of good coefficient of kinetic friction, good tensile strength, good elongation rate and good softness, and good safety, comprising no inflammatory potential, no cytotoxicity, no pyrogen, no acute systemic toxicity and no intradermal irritation potential, and has the efficacy of promotion of collagen formation, thereby being suitable for embedding in the face. The present invention further provides a cosmetic treatment and a manufacturing method for the surgical thread.

Abstract: An object of the present invention is to provide a fibrin composition manufactured by a method as a substitute for a method for manufacturing platelet-rich fibrin (PRF) triggered by the activation of a coagulation factor, a substrate for regenerative medicine using the fibrin composition, a method for manufacturing a fibrin composition, and a kit for being used in the method. According to the present invention, there is provided a fibrin composition including blocks, which each include a protein having repetitive Arg-Gly-Asp sequences derived from human collagen, fibrin, and platelets.

Abstract: The present invention relates to: a filler composition for reducing skin wrinkles, comprising stem cell-derived exosomes, hyaluronic acid, and BDDE; and a method for preparing same. The filler composition for reducing skin wrinkles according to the present invention not only overcome limitations of low in-vivo engraftment rate and survival rate of cells, which are the biggest problems of treatment using stem cells, but also suppresses side effects caused by tumorigenesis of stem cells and the like and exhibits an excellent collagen production effect, and it has been confirmed that the filler composition increases the proliferation of fibroblasts and collagen production by activating anti-inflammatory macrophages. Thus, the filler composition is expected to be effectively used in treatments for anti-aging, filler injections for cosmetic purposes, or the like.

Abstract: A device for mixing a bone material with a liquid is provided. The device comprises a chamber having a proximal end and a distal end, and the bone material disposed within the chamber, the bone material comprising a DBM pellet of milled and lyophilized demineralized bone fibers; and a plunger having at least a portion slidably disposed within the proximal end of the chamber and configured to dispense the bone material mixed with liquid from the distal end of the chamber, when the plunger is in an extended position.

Abstract: The present disclosure provides meshed acellular dermal tissue matrix compositions, devices, and methods of use. The meshed devices can be used in conjunction with a variety of implants such as breast implants or tissue expanders.

Abstract: Disclosed herein are muscle implants and methods of making muscle implants comprising one or more decellularized muscle matrices. The muscle matrices can be provided in a particulate form suitable for injection or implantation.

Abstract: Autologous 3D fat grafting and modification of adipose tissue lipoaspirate rich in stem cells with biocompatible cellulose nanofibrils (CNF) or collagen nanofibrils to achieve processable dispersion/emulsion which can be formed into a 3D shape(s) with desired porosity. 3D construct formed is further crosslinked either in situ at the implantation site or before implantation. Grafting can be performed in human or animal to correct soft tissue contour deformities in reconstructive and aesthetic surgery, including but not limited to injection, moulding, or 3D bioprinting. Biocompatible cellulose or collagen nanofibrils act as a dispersant/emulsifier of disintegrated lipoaspirate and provide shear thinning properties which make it possible to process dispersion into 3D shape yet provide porosity for nutrient diffusion and neovascularization. Invention further comprises a crosslinker(s) to provide construct's mechanical stability and ability to be transplanted as larger structure.

Abstract: The approach described herein uses the spatially and temporally controlled growth for programming 3D shapes and their motions, possibly with an unlimited number of degrees of freedom, could thus create dynamic 3D structures. The ability to program growth-induced 3D shapes and motions could transform the way engineering systems, such as robots, actuators, and artificial muscles, are designed. The concept is applicable to other programmable materials. The 2D printing approach for 3D material programming represents a scalable and customizable 3D manufacturing technology, which can potentially be integrated with biological systems and existing 2D fabrication methods and devices for broader applications.

Abstract: Provided herein are devices and methods for treating inflammation and pain of articular joints (e.g., the knee). An implantable device includes an elongate body extending from a proximal end to a distal end, a flange disposed at the proximal end, a bore extending from an opening at the proximal end into the elongate body, one or more fixation members disposed on an outer surface of the elongate body, and a payload (e.g., a drug-polymer core) having a therapeutic agent disposed within the bore. The payload has a substantially constant surface area on an exposed portion throughout elution of the therapeutic agent after the implantable device is implanted in a body. The therapeutic agent is configured to elute using zero-order kinetics, constantly and continuously at an amount that is above a predetermined lower threshold and does not exceed a predetermined upper threshold unlike a pulse-dose injection.

Abstract: The present disclosure provides improved compositions comprising a solution of a platelet-derived growth factor and a biocompatible matrix that are useful for bone fusion procedures, such as spine fusion procedures. The compositions advantageously comprise a the PDGF solution and biocompatible matrix in about a 2:1 volume to weight (mL:g) ratio such that the compositions can be readily applied to a site of bone fusion using a syringe or cannula. In particular embodiments, the composition is useful in conjunction with a spine fusion cage in a spine fusion procedure. The present disclosure also provides methods of performing fusion procedures, such as spine fusion, and kits for fusion procedures.

Abstract: A composite material can include a gel and at least one nanostructure disposed within the gel. A method for healing a soft tissue defect can include applying a composite material to a soft tissue defect, wherein the composite material includes a gel and a nanostructure disposed within the gel. A method for manufacturing a composite material for use in healing soft tissue defects can include providing a gel and disposing nanofibers within the gel.

Abstract: A polytetrafluoroethylene tube is provided and has a thickness of 0.1 mm or less, a tensile elongation at break of 350% or more, and a melting energy of 0.6 J/g or more which is calculated from an endothermic peak at 370° C.±5° C. in a procedure of increasing a temperature in differential scanning calorimetry (DSC).

Abstract: A medical coating agent contains a polymer including a structural unit (A) derived from an ethylenically unsaturated monomer having a urethane bond. The polymer has a glass transition temperature of ?25° C. or lower in a saturated hydration state, the state being defined as such a hydration state of the polymer that the top of the endothermic peak attributed to melting of ice emerges at 0° C. in a DSC curve obtained when the polymer which has been hydrated is heated by means of a differential scanning calorimeter (DSC) at a rate of 5° C./minute.

Abstract: This invention relates to a flange adapter for a flange used in a suction activated silicone collection cup. The flange adapter comprises a body defining a sidewall and an axial passageway. The body comprises a first end and a second end having a first diameter and a second diameter respectively, wherein the second diameter is greater than the first diameter. The body comprises at least one rib on its sidewall that enables it to be removably sealably engaged with an internal passage of the flexible flange. The second end has a frusto-conical shape. The flange adapter further comprises a removable section configured to be sealably engaged with the first end, wherein the removable extension comprises an axial passageway that coincides with the axial passageway of the flange adapter. The flange adapter and the removable section is made of a flexible polymeric material such as polyethylene, silicone, or combinations thereof.

Abstract: A dialysis system has a plurality of hydraulically connected components and a control device. A method of operating the dialysis system includes the steps of receiving, by the control device, component operating data from at least one of the components, the component operating data including at least demand data indicating an expected resource consumption of the component for an upcoming task to be performed by the component, and determining, by the control device, operating parameters for coordinated operation of the components such that an expected resource consumption of the dialysis system is optimized. The step of determining the operating parameters includes determining at least one operating parameter for one or more of the components based on the component operating data and resource availability data and/or task prioritization data.

Abstract: A device for providing dialysis information receives a target dialysis conditional value indicating the target for the dialysis among the plurality of dialysis conditions, a plurality of known dialysis conditional values excluding the search dialysis conditional value and the target dialysis conditional value from the plurality of dialysis conditional values, and one or a plurality of patient-specific values set for each patient. The device for providing dialysis information further obtains the search dialysis conditional value satisfying the target dialysis conditional value by using a predicted toxin concentration obtained by substituting a patient test value, the known dialysis condition and the patient-specific value into an extracellular fluid toxin concentration function indicating a temporal change in concentration of a toxin to be removed contained in extracellular fluid of the patient.

Abstract: A modular assembly for a portable hemodialysis system may include a dialysis unit, e.g., that contains suitable components for performing hemodialysis, such as a dialyzer, one or more pumps to circulate blood through the dialyzer, a source of dialysate, and one or more pumps to circulate the dialysate through the dialyzer, and a power unit having a housing that contains suitable components for providing operating power to the pumps of the dialysis unit. The power unit may be selectively connected to the dialysis unit and provide power (e.g., pneumatic power in the form of pressure and/or vacuum) to the dialysis unit for the pumps when connected to the dialysis unit, but may be incapable of providing power to the dialysis unit when disconnected from the dialysis unit. The dialysis unit and the power unit are sized and weighted to each be carried by hand by a human.

Abstract: Direct sodium removal (“DSR”) therapy methods are provided for removing sodium and reducing fluid overload in patients with renal failure or heart failure, in which a patient has at least first and second DSR treatments with an infusate comprising 15-40 wt % icodextrin and up to 15 wt % dextrose that is instilled into a patient's peritoneal cavity for dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, after which the infusate, sodium and ultrafiltrate is removed from the peritoneal cavity.

Abstract: A system includes an intravascular reperfusion therapy device configured to be positioned within a coronary vein to deliver reperfusion therapy to a myocardium of a heart associated with the coronary vein. The intravascular reperfusion therapy device includes a flexible elongate member, a sensor, and a balloon. The balloon is configured to generate back pressure within the coronary vein to deliver the reperfusion therapy. The system includes a processor circuit in communication with the intravascular reperfusion therapy device.

Abstract: A device for delivering a flowing media is provided. For example, a device for delivering a flowing media may include a housing defining an opening, a first printed circuit board assembly (PCBA), a fluid-resistant seal occluding the opening, and a sensor module. The sensor module comprises a second PCBA having a plurality of electrical contact pads; a sensing element in electrical communication with one or more of the electrical contact pads; and a flow tube at least partially defining a flow path for conveying a flowing media therethrough. The flow tube comprises an elongated main body disposed proximate the first major surface of the second PCBA such that the flow path is disposed proximate the sensing element such that at least a portion of the flowing media makes direct contact with the sensing element. The sensor module is selectively mechanically and electrically attachable to the device.

Abstract: According to embodiments, priming systems, methods, and devices are disclosed which allow medical treatment devices which pump fluid to be primed with minimal operator intervention and a high level of convenience. A blood circuit with a filter fitted with one or more air vents on a non-blood compartment is attached to a treatment system and priming fluid pumped slowly through the blood circuit in a loop. The source of fluid may be elevated, or the pumping may generate pressure, such that priming fluid is forced through the membrane of the filter and out the air vent(s). In embodiments, the vents are hydrophobic which prevent fluid from being ejected, so the priming system can run without intervention.

Abstract: A polychromatic phototherapy device for blood treatment including a casing having a triple quartz tube cuvette assembly removably installed in the casing, with blood to be treated passing through the cuvette. A plurality of light sources are mounted in the casing adjacent the cuvette to project focused light onto the blood flowing through the cuvette. The light sources include a dual wavelength UVA light source, a UVC light source, and dual wavelength red, an amber, a green and a blue LED light sources. Each of the LED light sources includes a lens assembly that projects a concentrated, highly focused linear light beam on one of the quartz tubes of the cuvette through which the blood is flowing. Once blood has been withdrawn from a patient and treated in the polychromatic phototherapy device, the blood is reinfused back into the patient.

Abstract: A case for transporting a substance such as a messenger RNA vaccine, including a container, a damping material contained in the container and a storage structure immersed in the damping product, the storage structure forming cavities for receiving syringes containing said substance.

Abstract: A system of medical indicators includes a set of medical indicator tags, each of which includes a first plurality of identifying characteristics that are indicative of a category of therapy and a second plurality of identifying characteristics that are indicative of a specific therapy within the category of therapy, wherein the set includes a first indicator tag including the first plurality of identifying characteristics that are indicative of a first category of therapy and the second plurality of identifying characteristics that are indicative of a first specific therapy within the first category of therapy, and a second indicator tag including the first plurality of identifying characteristics that are indicative of the first category of therapy and the second plurality of identifying characteristics that are indicative of a second specific therapy within the first category of therapy.

Abstract: A pump includes a reservoir, a port, and a plunger. The reservoir delivers a liquid by discharging the liquid through the port coupled to the reservoir. A piston of the plunger defines a liquid side of the reservoir and a non-liquid side of the reservoir whereby movement of the plunger towards the liquid side of the reservoir discharges liquid through the port. The pump also includes a reference-volume assembly and/or a linear position sensor. The reference-volume assembly is coupled to the reservoir at an opposite end of the reservoir relative to the port and includes a reference-volume chamber in acoustic communication with the non-liquid side of the reservoir, a speaker disposed within the reference-volume chamber, and a reference microphone disposed within the reference-volume chamber. The pump estimate the amount of liquid discharged from the reservoir.

Abstract: An electronic device according to the present disclosure is an electronic device on which a mounting body can be mounted so as to cover an opening communicating with inside in which an electronic component is stored, the electronic device including at least an eccentric side view in which, in a case in which a surface on which the opening is formed is set as an upper surface and a surface located on an opposite side of the upper surface is set as a lower surface, a lower end portion of the lower surface, which is located on a lowest side in a vertical direction, is located only on one side of a virtual centroidal line extending downward in the vertical direction from a center of gravity of the electronic device in any side view in a vertical posture in which the upper surface is directed upward in the vertical direction.

Abstract: In some embodiments, an infusion device can include a reservoir configured to hold a medicament, a first epicyclic gear arrangement comprising a first output, a second epicyclic gear arrangement comprising a second output, a first trocar coupled to the first output and movably coupled to a sensor electrode, and a second trocar coupled to the second output and movably coupled to an infusion cannula that is fluidically coupled to the reservoir. Actuation of the first epicyclic gear arrangement can drive linear travel of the first trocar and/or the sensor electrode, and actuation of the second epicyclic gear arrangement can drive linear travel of the second trocar and/or the infusion cannula.

Abstract: A device for delivering fluid and an inserter in a device for delivering fluid, the device comprising an annular guide configured to engage a pen or a syringe injection needle, a main body enclosed by a base and a cover, and an inserter for expelling the fluid, wherein the inserter includes a glucose monitoring sensor disposed coaxially with the inserter. The inserter comprising a cannula configured to deliver the fluid, and a glucose monitoring sensor disposed coaxially to and surrounding the cannula, wherein the glucose monitoring sensor includes a biosensor layer that monitors glucose in the fluid and provides feedback to the device.

Abstract: Drug delivery device, drug delivery system, and system components are provided including configuration of a container, reservoir or barrel for medium or fluid and a pump mechanism or driving components for advancing a plunger to dispense the medium or fluid from the reservoir or barrel, and/or for filling the reservoir or barrel with the medium or fluid, where the pumping mechanism or driving components are disposed such that individual and/or overall dimensions of the pump mechanism or the driving components can be reduced compared to conventional designs. A provided system can include a syringe-style drug container, reservoir, or barrel containing a medium or fluid which can be dispensed by a pumping mechanism configured to advance a plunger/stopper disposed inside the barrel via cable, or a ribbon, connected to the plunger/stopper.

Abstract: An infusion system comprising: a device for delivering insulin to a user, the device configured to be mounted the user; a CGM sensor for measuring glucose level in the user and an infusion needle for delivering the insulin to the user; a needle cartridge assembly for supporting the CGM sensor and/or the infusion needle, the needle cartridge assembly configured to move from (1) a telescoping position above the device for delivering insulin, wherein the CGM sensor and/or infusion needle are/is in a retracted position within the device for delivering insulin to (2) an advanced position within the device, wherein the infusion needle and/or CGM sensor are/is in a deployed position inserted into a subcutaneous tissue of the user's skin; and a detachable activation mechanism for (a) moving the needle cartridge assembly from the telescoping position to the advanced position and for (b) releasing the device for delivering insulin upon activation of the detachable activation by the user.

Abstract: Disclosed in the present application is a vertical indwelling needle assembly, including a base body, an interior of the base body is provided with an infusion chamber, a straight channel and an infusion channel; the transverse channel is provided proximal to a bottom of the base body; the connecting channel is used to communicate the infusion chamber with the transverse channel; the transverse channel extends transversely to an exterior surface of the base body to form an external opening; an interior of the transverse channel is provided with a second flexible sealing member; and the second flexible sealing member is provided between a connecting opening and the external opening.

Abstract: In one aspect, a drug delivery device is provided herein including: a monolithic body having a plurality of fluid ducts and at least one outlet duct formed therein; a plurality of drug cartridges attached to the body, the drug cartridges each including a reservoir for accommodating at least one drug wherein, the plurality of fluid ducts is arranged to convey the drugs from the drug cartridges to the at least one outlet duct; and, a needle support spaced from the body, the needle support including a needle configured for insertion into a patient for drug delivery, the needle support including adhesive for releasable securement to a patient, wherein, the needle support is connected to the body by a flexible tether through which passes at least one fluid passageway formed to convey drug from the at least one outlet duct to the needle.

Abstract: Methods and apparatus for introducing a steady state concentration of a psychotropic drug are provided. The apparatus comprises a computer assisted diffusion pump that allows for the maintenance of a desired concentration of the drug for an extended period of time. The apparatus also provides a modified needle for intramuscular administration of the drug. The method allows for treatment of a variety of indications including stress, depression, anxiety and insomnia as well as addictive disorders including alcohol, cigarette addiction and drug addiction.

Abstract: Methods and systems for configuring a plurality of infusion pumps according to a functional set. A method includes implementing a plurality of infusion pumps, each of the infusion pumps configured to administer medication to a patient, implementing a drug library, the drug library including at least one functional set defining a set of medications, receiving input data related to one of the at least one functional sets, obtaining a particular set of medications from the drug library corresponding to the input data, programming the plurality of infusion pumps according to the set of medications, and infusing the patient with the plurality of infusion pumps.

Abstract: A system and method to configure a rule set used in connection with a medical monitoring system for monitoring patients and patient care equipment, especially medication delivery pumps, based on a variety of conditions and parameters associated with monitored biometric information and equipment information and for providing user-defined responses to those conditions and parameters.

Abstract: An electronics device provided for a drug delivery device or a drug delivery add-on device is disclosed, wherein the drug delivery device or the drug delivery add-on device comprises a dose measurement function and a data transmission function. The electronics device comprises at least one first controller unit being provided for controlling dose related functions of the drug delivery device or drug delivery add-on device and for data processing functions comprising one or more first numerical calculations with dose related data, and at least one second controller unit being provided for data processing functions comprising one or more second numerical calculations with dose related data having a higher complexity than the first numerical calculations and communication functions, wherein the at least one first controller unit is designed for using less power than the at least one second controller unit.

Abstract: A drug delivery device includes a housing having proximal and distal ends and a longitudinal axis extending therebetween, an injection assembly at least partially disposed within the housing including a needle or a cannula, a drive assembly operably coupled with the injection assembly, a shield slidably coupled with the housing and operably coupled with the drive assembly, and a retention mechanism. The drive assembly is engageable to deliver a medicament via the injection assembly. The shield is positionable in an extended position in which at least a proximal end extends a distance beyond the proximal end of the housing and a retracted position where the proximal end of the housing protrudes a distance beyond the proximal end of the shield. Moving the shield to the retracted position engages the drive assembly to deliver the medicament via the injection assembly.

Abstract: The present disclosure relates to a medicament delivery device sub-assembly having an injection needle assembly, a cartridge and a seal. The injection needle assembly has opposite distal and proximal ends, and has a retainer member configured to be connectable to a medicament container; a hub configured to be coaxially displaceable within the retainer member and provided with an injection needle having proximal and distal pointed ends; and a cap member interactively connected to both the hub and to the retainer member. A sealing member can be arranged between the cap member and the retainer member for preventing contamination of the injection needle before use. The seal seals a gap between the injection needle assembly and the cartridge. Methods of assembly are also described.

Abstract: A device for injecting medicinal solutions and liquid drugs in general by Carpule type syringes or the like, wherein the drug is contained in a tube having a proximal end or upper end with a plunger actionable by means of the stem of the Carpule syringe or the like, and a distal end or lower end with a plug of pierceable elastomeric material with the needle end fixed in a needle-holder piece. The distal end or lower end of the tube and the needle-holder piece are linked in the form of a male/female coupling, where the male part is the distal end of the tube and the female part is defined in a rear section of the needle-holder piece. The inlet end of the needle passes tightly through the front section of the needle-holder.

Abstract: A pre-filled blow-fill-seal (BFS) IntraDermal (ID) medical agent injection system assembled and configured to allow delivery of a single dose of a therapeutic agent (e.g., vaccine, drug, medicament, etc.) from a BFS vial to a patient in an auto-disable fashion.

Abstract: A jet injection and electroporation device for use with an agent cartridge defining a volume containing a pre-measured dose of agent therein, the electroporation device including a housing having an axis extend therethrough, a nozzle at least partially positioned within the housing, and a cavity sized to receive at least a portion of the agent cartridge therein. The device also includes an array having a plurality of electrodes extending therefrom, a propulsion cartridge configured to operatively engage the cartridge when the agent cartridge is positioned within the cavity; and a power supply in electrical communication with the array.

Abstract: Proposed is an injector in which when a solution containing biomolecules is injected into an injection target, a proportion of biomolecules that function in the injection target with respect to the injected biomolecules is large. This application also relates to a method of injecting a solution containing biomolecules into an injection target using the injector. In one aspect, the injector injects the solution containing biomolecules into the injection target from an injector main body without performing injection through a given structure in a state where the given structure is inserted into the injection target. The injector may include an accommodation unit and a nozzle unit, wherein the injector satisfies a given condition.